A novel “patient‐like” model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines†‡

Alphonse E. Sirica(Virginia Commonwealth University), Jennifer L. DeWitt(Virginia Commonwealth University)

Hepatology

December 14, 2007

10.1002/hep.22088

Cited by 83

Related Papers

Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances

|Hepatology|2018|340

Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation

|Hepatology|2004|120

Preclinical Assessment of Simultaneous Targeting of Epidermal Growth Factor Receptor (ERBB1) and ERBB2 as a Strategy for Cholangiocarcinoma Therapy†,‡

|Hepatology|2010|44

Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model

|American Journal Of Pathology|2017|22